Secondly, Osaki et al. reported a reduction in tumor-infiltrating CD8+ T cells in tumors that were excised at day 6 of tumor growth [30], a point at which the adaptive immune response is still developing and innate responses are likely to dominate. The gene discussed is CD8A; the disease is neoplasm.